Fundraising FoxTentarix Biotherapeutics, LP
La Jolla, US · Founded 2020 · Delaware limited partnership · 1 known investors
Find your way into Tentarix Biotherapeutics, LP
Sign up to see every warm intro you have to Tentarix Biotherapeutics, LP
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tentarix Biotherapeutics, LP team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Founders & leadership
AL
Alyssa LochbaumNamed on SEC filing
PK
Paul KangNamed on SEC filing
PG
Paul GraysonNamed on SEC filing
Board
CF
JD
Jerel DavisBoard director
SA
Investors · 1
Reported raises · per SEC filings
Form D private placements$43M disclosed across 2 rounds · 2020–2023
▶$35MraisedSep 2023 · 5 investors · BiotechnologyRule 506(b)
▶$35MraisedSep 2023 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul KangDirector
- Allyson TigheDirector
- Thomas F. BumolDirector
- Srinivas AkkarajuDirector
- Paul GraysonExecutive Officer, Director
- Jerel DavisDirector
- Margaret KarowExecutive Officer
- Stephen DemarestExecutive Officer
- Donald J. SantelDirector
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Aug 2023
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
▶$8MraisedSep 2020 · 4 investors · BiotechnologyRule 506(b)
▶$8MraisedSep 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cory FreedlandDirector
- Jerel DavisDirector
- Srinivas AkkarajuDirector
- Alyssa LochbaumExecutive Officer
- Paul KangDirector
- Paul GraysonExecutive Officer, Director
- Offering amount
- $50M
- Amount sold
- $8M
- First sale
- Jul 2020
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Tentarix Biotherapeutics, LP do?
- Creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
- Who are Tentarix Biotherapeutics, LP's investors?
- Tentarix Biotherapeutics, LP's investors include Samsara BioCapital.
- How much funding has Tentarix Biotherapeutics, LP raised?
- Tentarix Biotherapeutics, LP has disclosed $43M raised across 2 rounds.
- Where is Tentarix Biotherapeutics, LP headquartered?
- Tentarix Biotherapeutics, LP is headquartered in La Jolla, US.